Uvisio, a Netherlands-based startup founded in 2015, focuses on developing UV measuring devices and software aimed at promoting safe sun exposure to mitigate the risk of skin cancer. The company's health care-oriented approach emphasizes the need to balance the benefits of sunlight with the potential harms of overexposure. In July 2018, Uvisio secured a Seed Round investment from SmartWare.tech and Startupbootcamp Digital Health Berlin, signaling recognition and support from industry insiders. With its commitment to leveraging technology for public good, Uvisio presents a compelling opportunity for venture capital firms seeking to invest in sustainable healthcare solutions that prioritize individual well-being.
No recent news or press coverage available for Uvisio.